FDA Approves Theranica's Nerivio(R) for Acute Treatment of Migraine in Adolescents
VThe Prescribed Wearable Device is Now indicated for Patients 12 Years Old and Above
NETANYA, Israel and MONTCLAIR, N.J., Jan. 25, 2021 -- (Healthcare Sales & Marketing Network) -- Theranica, a prescribed digital therapeutics (PDT) company developing a... Devices, Neurology, FDA Theranica , prescribed digital therapeutics, Nerivio , migraine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Headache | Israel Health | Marketing | Middle East Health | Migraine | Neurology | Pharmaceuticals